Skip Navigation LinksHome > February 2011 - Volume 111 - Issue 2 > New Atypical Antipsychotic Approved
AJN, American Journal of Nursing:
doi: 10.1097/01.NAJ.0000394287.09836.54
Drug Watch

New Atypical Antipsychotic Approved

Aschenbrenner, Diane S. MS, APRN-BC

Collapse Box


* A new atypical antipsychotic drug, lurasidone (Latuda) has been approved to treat schizophrenia in adults.

* As with other drugs in this class, lurasidone isn't approved for older adults with dementia-related psychosis.

* Lurasidone has the same adverse effects profile as other atypical antipsychotics, including an increased risk of death, particularly from cerebrovascular causes.

© 2011 Lippincott Williams & Wilkins, Inc.


Article Level Metrics